Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Windisch

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Molecular Neuroscience : MN|December 25, 2010
The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's diseaseAnnamaria Lanzillotta, Ilenia Sarnico, Marina Benarese, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 12, 2010
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease modelNiall M Corcoran, Daniel Martin, Birgit Hutter-Paier, et al.
Journal of Neuropathology and Experimental Neurology|July 9, 2010
The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic miceHenri J Huttunen, Daniel Havas, Camilla Peach, et al.
Neurotoxicity Research|July 9, 2015
Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot StudyAmit Khairnar, Peter Latta, Eva Drazanova, et al.
Alzheimer'S Research & Therapy|January 8, 2011
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's diseaseRandall J Bateman, Paul S Aisen, Bart De Strooper, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2008
Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patientsMichael Willis, Manuela Prokesch, Birgit Hutter-Paier, et al.
Journal of Neurochemistry|December 20, 2015
Late-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imagingAmit Khairnar, Jana Ruda-Kucerova, Eva Drazanova, et al.
Vaccine|February 9, 2007
Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's diseaseChang Yi Wang, Connie L Finstad, Alan M Walfield, et al.
Nature Medicine|May 17, 2024
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trialHayley R C Shanks, Kewei Chen, Eric M Reiman, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Molecular Neuroscience : MN|December 25, 2010
The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's diseaseAnnamaria Lanzillotta, Ilenia Sarnico, Marina Benarese, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutationsMichael Willis, Walter A Kaufmann, Georg Wietzorrek, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 12, 2010
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease modelNiall M Corcoran, Daniel Martin, Birgit Hutter-Paier, et al.
Journal of Neuropathology and Experimental Neurology|July 9, 2010
The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic miceHenri J Huttunen, Daniel Havas, Camilla Peach, et al.
Neurotoxicity Research|July 9, 2015
Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot StudyAmit Khairnar, Peter Latta, Eva Drazanova, et al.
Alzheimer'S Research & Therapy|January 8, 2011
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's diseaseRandall J Bateman, Paul S Aisen, Bart De Strooper, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2008
Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patientsMichael Willis, Manuela Prokesch, Birgit Hutter-Paier, et al.
Journal of Neurochemistry|December 20, 2015
Late-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imagingAmit Khairnar, Jana Ruda-Kucerova, Eva Drazanova, et al.
Vaccine|February 9, 2007
Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's diseaseChang Yi Wang, Connie L Finstad, Alan M Walfield, et al.
Nature Medicine|May 17, 2024
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trialHayley R C Shanks, Kewei Chen, Eric M Reiman, et al.
Pageof 6